Proteome Sciences had released its new β-amyloid mass spec workflow for quantification of Aβ species in cerebrospinal fluid.

The workflow is intended for research use and early stage clinical trial work and can detect and quantify 14 different Aβ species above 0.5 ng/ml with coefficients of variation of less than 20 percent, the company said.


Meso Scale Discovery has launched its V-PLEX biomarker tests, a line of validated immunoassays for clinical research.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Cornell's Christopher Mason and his colleagues correct their New York City microbiome study to emphasize "the difference between matching fragments of DNA from a species and a pathogen."

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.

A National Science Foundation-funded project aims to give researchers access to a network many times faster than the Internet.

Bioethicists weigh the idea of charging patients to take part in clinical research, coming down against the approach.